Catalyst Capital Advisors LLC - CATALYST PHARMACEUTICALS INC ownership

CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 48 filers reported holding CATALYST PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is 0.01 and the average weighting 0.2%.

Quarter-by-quarter ownership
Catalyst Capital Advisors LLC ownership history of CATALYST PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2015$748,000
-18.3%
305,0000.0%0.11%
-12.2%
Q3 2015$915,000
-83.1%
305,000
-76.7%
0.12%
-80.5%
Q2 2015$5,411,000
+16.2%
1,310,000
+21.9%
0.63%
+18.2%
Q1 2015$4,655,000
+64.1%
1,075,000
+12.6%
0.53%
+60.4%
Q4 2014$2,836,000
-10.6%
955,0000.0%0.33%
-18.6%
Q3 2014$3,171,000
+51.0%
955,000
+15.1%
0.41%
+19.2%
Q2 2014$2,100,000830,0000.34%
Other shareholders
CATALYST PHARMACEUTICALS INC shareholders Q2 2014
NameSharesValueWeighting ↓
TANAKA CAPITAL MANAGEMENT INC 213,609$1,446,0002.75%
GABLES CAPITAL MANAGEMENT INC. 449,164$3,041,0001.81%
Prairiewood Capital, LLC 261,403$1,770,0001.40%
ARMISTICE CAPITAL, LLC 9,572,000$64,802,0001.06%
Quantedge Capital Pte Ltd 360,100$2,438,0001.03%
SummerHaven Investment Management, LLC 151,384$1,025,0000.55%
GLOBEFLEX CAPITAL L P 609,030$4,124,0000.42%
EAM Global Investors LLC 347,899$2,355,0000.42%
Lanham O'Dell & Company, Inc. 50,000$339,0000.27%
EAM Investors, LLC 239,071$1,619,0000.27%
View complete list of CATALYST PHARMACEUTICALS INC shareholders